AbbVie CEO Richard Gonzalez has a tough choice: hold down prices of its best-selling drug and depress growth or turn AbbVie into a whipping boy for anger over high prescription costs.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180725/BLOGS10/180729951/abbvies-humira-dilemma?utm_source=BLOGS10&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment